SJUTS DUSTIN S (Chief Commercial Officer) received a stock award from REVANCE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/15/2023ACC: 0001479290-23-000097
Officer· Chief Commercial Officer
Since Dec 2019
+13.72K
Net shares
Net buyer
$168.3K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
22.62K acquired · 8.90K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+22.62K
Price / share
—
Trade value
—
% of position
15.2%
8/11/2023
148.35K→170.97K
Common Stock
Direct
Shares
−8.90K
Price / share
$18.91
Trade value
$168.32K
% of position
5.2%
8/11/2023
170.97K→162.07K
Total
Net shares
+13.72K
Net value
-$168.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/11/2023 | A · Award | +22.62K | — | — | 15.2% | 148.35K | 170.97K |
| Common Stock Direct | 8/11/2023 | F · Tax Withholding | −8.90K | $18.91 | $168.32K | 5.2% | 170.97K | 162.07K |
| Total | +13.72K | -$168.32K | ||||||
Derivative Transactions0
No derivative transactions reported